Similar Items: GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer
- Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
- Meaningful Radiographic and Metabolic Response to Enzalutamide Plus Radium‐223 Therapy in Metastatic Castration‐Resistant Prostate Cancer With PSA‐Discordant Progression: A Case Report
- Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancer
- Real-World Treatment Patterns and Overall Survival (OS) of Patients with Metastatic Castration-Resistant Prostate Cancer in Italy
- Evaluation of Pinhole Castration Techniques Compare with Traditional Method for Castration in Rabbits
- Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis